| MeSH term | MeSH ID | Detail |
|---|---|---|
| Radicular Cyst | D011842 | 2 associated lipids |
| Gingival Recession | D005889 | 2 associated lipids |
| Carcinoma, Medullary | D018276 | 2 associated lipids |
| Dengue | D003715 | 2 associated lipids |
| Foot Deformities, Acquired | D005531 | 2 associated lipids |
| Tooth Migration | D014085 | 2 associated lipids |
| Musculoskeletal Diseases | D009140 | 2 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| No-Reflow Phenomenon | D054318 | 2 associated lipids |
| Ossification, Heterotopic | D009999 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Daroszewska A and Ralston SH | Mechanisms of disease: genetics of Paget's disease of bone and related disorders. | 2006 | Nat Clin Pract Rheumatol | pmid:16932700 |
| Swolin-Eide D et al. | The novel bone alkaline phosphatase B1x isoform in children with kidney disease. | 2006 | Pediatr. Nephrol. | pmid:16932897 |
| Kawai T et al. | B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. | 2006 | Am. J. Pathol. | pmid:16936272 |
| Adamopoulos IE et al. | Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis. | 2006 | Hum. Pathol. | pmid:16938523 |
| Wang Y et al. | Role of IGF-I signaling in regulating osteoclastogenesis. | 2006 | J. Bone Miner. Res. | pmid:16939393 |
| Asaba Y et al. | Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. | 2006 | Bone | pmid:16942925 |
| Chen T et al. | High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor. | 2006 | Assay Drug Dev Technol | pmid:16945012 |
| Chen T and Feng X | Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors. | 2006 | Assay Drug Dev Technol | pmid:16945019 |
| Ueland T et al. | No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. | 2007 | Bone | pmid:16949901 |
| Maruyama K et al. | Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. | 2006 | J. Immunol. | pmid:16951341 |
| Nakamichi Y and Udagawa N | [Role of OPG in regulation of bone remodeling]. | 2006 | Clin Calcium | pmid:16951469 |
| Yasui T and Tanaka S | [Current topics in drug therapy aiming at bone resorption]. | 2006 | Clin Calcium | pmid:16951471 |
| Jung K et al. | Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma. | 2006 | J. Urol. | pmid:16952623 |
| Soedarsono N et al. | Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis. | 2006 | J. Periodont. Res. | pmid:16953816 |
| Hu Y et al. | Effect of triptolide on expression of receptor activator of nuclear factor-kappaB ligand in rat adjuvant induced arthritis. | 2006 | J. Huazhong Univ. Sci. Technol. Med. Sci. | pmid:16961289 |
| Kim YH et al. | Dexamethasone inhibits the formation of multinucleated osteoclasts via down-regulation of beta3 integrin expression. | 2006 | Arch. Pharm. Res. | pmid:16964765 |
| Stankovic KM and McKenna MJ | Current research in otosclerosis. | 2006 | Curr Opin Otolaryngol Head Neck Surg | pmid:16974150 |
| Martini G et al. | Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. | 2007 | Bone | pmid:16979395 |
| Bargnoux AS et al. | Renal transplantation decreases osteoprotegerin levels. | 2006 | Transplant. Proc. | pmid:16980077 |
| Kobayashi-Sakamoto M et al. | Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases. | 2006 | FEMS Microbiol. Lett. | pmid:16981905 |
| Grzegorzewska AE and Mlot-Michalska M | Serum markers of bone turnover in dialyzed patients grouped by level of intact parathyroid hormone. | 2006 | Adv Perit Dial | pmid:16983970 |
| Baldock PA et al. | Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. | 2006 | J. Bone Miner. Res. | pmid:16995817 |
| Luo XH et al. | Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. | 2006 | J. Bone Miner. Res. | pmid:16995820 |
| Casado-DÃaz A et al. | Individual single tube genotyping and DNA pooling by allele-specific PCR to uncover associations of polymorphisms with complex diseases. | 2007 | Clin. Chim. Acta | pmid:16999948 |
| Kantaputra PN et al. | A newly recognized polyosteolysis/hyperostosis syndrome. | 2006 | Am. J. Med. Genet. A | pmid:17001672 |
| Kim HK et al. | RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis. | 2006 | J. Bone Miner. Res. | pmid:17002576 |
| Koreny T et al. | The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. | 2006 | Arthritis Rheum. | pmid:17009257 |
| Kahl KG et al. | Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. | 2006 Sep-Oct | Psychosom Med | pmid:17012519 |
| Zdzisińska B and Kandefer-Szerszeń M | [The role of RANK/RANKL and OPG in multiple myeloma]. | 2006 | Postepy Hig Med Dosw (Online) | pmid:17013366 |
| Perifanis V et al. | Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia. | 2007 | Ann. Hematol. | pmid:17013645 |
| Samadfam R et al. | Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice. | 2007 | J. Bone Miner. Res. | pmid:17014384 |
| Ulivieri FM et al. | Increased osteoprotegerin in Italian haemodialysis patients. | 2006 | Osteoporos Int | pmid:17019516 |
| Okazaki T | [PTH-related protein producing tumor]. | 2006 | Nippon Rinsho | pmid:17022555 |
| Xiang GD et al. | Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients. | 2007 | Diabetes Res. Clin. Pract. | pmid:17023086 |
| Zangari M et al. | Response to bortezomib and activation of osteoblasts in multiple myeloma. | 2006 | Clin Lymphoma Myeloma | pmid:17026821 |
| Jiang SD et al. | Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats. | 2007 | Osteoporos Int | pmid:17036173 |
| Eriksen EF et al. | Remodeling and vascular spaces in bone. | 2007 | J. Bone Miner. Res. | pmid:17040170 |
| Ostergård T et al. | Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. | 2006 | Metab. Clin. Exp. | pmid:17046554 |
| Clancy P et al. | Assessment of a serum assay for quantification of abdominal aortic calcification. | 2006 | Arterioscler. Thromb. Vasc. Biol. | pmid:17053174 |
| Wang FS et al. | Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. | 2007 | Bone | pmid:17055793 |
| Olesen P et al. | Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. | 2007 | Am. J. Physiol. Heart Circ. Physiol. | pmid:17056676 |
| Pearse RN | Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling. | 2006 | Clin. Cancer Res. | pmid:17062713 |
| Ge WL et al. | [Expression of c-fos, OPG, OPGL in rabbit mandibular distraction osteogenesis zone]. | 2006 | Zhejiang Da Xue Xue Bao Yi Xue Ban | pmid:17063541 |
| Sato M et al. | New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro. | 2007 | Bone | pmid:17070129 |
| Ben-Tal Cohen E et al. | Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro. | 2007 | Biochem. Pharmacol. | pmid:17070781 |
| Maruyama K et al. | Murine osteoblasts respond to LPS and IFN-gamma similarly to macrophages. | 2006 | J. Bone Miner. Metab. | pmid:17072737 |
| Di Carlo C et al. | Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. | 2007 Jan-Feb | Menopause | pmid:17075432 |
| Yamamoto T et al. | Cytokine production in human periodontal ligament cells stimulated with Porphyromonas gingivalis. | 2006 | J. Periodont. Res. | pmid:17076781 |
| Matsumoto K et al. | Cytokine profile in synovial fluid from patients with internal derangement of the temporomandibular joint: a preliminary study. | 2006 | Dentomaxillofac Radiol | pmid:17082335 |
| Weinstock-Guttman B et al. | Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. | 2006 | Mult. Scler. | pmid:17086898 |
| Zheng Y et al. | Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. | 2007 | Bone | pmid:17092788 |
| Tang CH et al. | Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. | 2007 | J. Biol. Chem. | pmid:17099218 |
| Terpos E et al. | Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. | 2006 | Br. J. Haematol. | pmid:17107351 |
| Alexopoulou O et al. | Bone density and markers of bone remodeling in type 1 male diabetic patients. | 2006 | Diabetes Metab. | pmid:17110900 |
| Gogo PB et al. | Osteoprotegerin is not associated with angiographic coronary calcification. | 2006 | J. Thromb. Thrombolysis | pmid:17111200 |
| Saldaña L et al. | Thermal oxidation enhances early interactions between human osteoblasts and alumina blasted Ti6Al4V alloy. | 2007 | J Biomed Mater Res A | pmid:17120220 |
| van Lent PL et al. | Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. | 2006 | Arthritis Rheum. | pmid:17133594 |
| Fietta P and Manganelli P | A case of hepatitis C-associated osteosclerosis in an elderly man. Comment on the article by Tanaka et al. | 2007 | Endocr. J. | pmid:17135709 |
| Shumakov VI et al. | [The peculiarities of bone exchange disorder and its regulation in men after long terms following orthotopic heart transplantation and cadaveric kidney transplantation]. | 2006 | Vestn. Akad. Med. Nauk SSSR | pmid:17136849 |
| Martini G et al. | The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma. | 2006 | Haematologica | pmid:17145616 |
| Pan G et al. | Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors. | 2006 | AIDS Res. Hum. Retroviruses | pmid:17147500 |
| Vistoropsky Y et al. | Osteoprotegerin plasma levels are strongly associated with polymorphisms in human homologue of the mouse progressive ankylosis (ANKH) gene. | 2007 | Ann. Hum. Genet. | pmid:17147692 |
| Secchiero P et al. | An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. | 2006 | Am. J. Pathol. | pmid:17148684 |
| Sato K | [Graves' disease and bone metabolism]. | 2006 | Nippon Rinsho | pmid:17154099 |
| Harding G et al. | The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA. | 2006 | Cytokine | pmid:17161616 |
| Ricci P et al. | Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation. | 2006 | Transplantation | pmid:17164716 |
| Bandow K et al. | Low-intensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1beta expression in osteoblasts through the angiotensin II type 1 receptor. | 2007 | J. Cell. Physiol. | pmid:17167786 |
| Ivanov SD et al. | [Prognosis of efficacy of organ-saving treatment of invasive bladder cancer]. | 2006 | Vopr Onkol | pmid:17168368 |
| Tintut Y and Demer L | Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification. | 2006 | J. Investig. Med. | pmid:17169261 |
| Schoppet M et al. | Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent. | 2007 | J. Cell. Biochem. | pmid:17171649 |
| Kiechl S et al. | The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. | 2006 | Expert Rev Cardiovasc Ther | pmid:17173497 |
| Blair JM et al. | RANK ligand. | 2007 | Int. J. Biochem. Cell Biol. | pmid:17174136 |
| Dougall WC and Chaisson M | The RANK/RANKL/OPG triad in cancer-induced bone diseases. | 2006 | Cancer Metastasis Rev. | pmid:17180711 |
| Nakamichi Y et al. | Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. | 2007 | J. Immunol. | pmid:17182555 |
| Sato T et al. | Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. | 2007 | J. Bone Miner. Metab. | pmid:17187190 |
| Angelopoulos NG et al. | Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major. | 2007 | J. Bone Miner. Metab. | pmid:17187195 |
| Endres S et al. | [Comparative in vitro analysis of vacuum plasma-sprayed titanium implants--evaluation of OPG, Osteokalzin and AP expression]. | 2006 Nov-Dec | Z Orthop Ihre Grenzgeb | pmid:17187340 |
| Vandyke K et al. | Androgen decreases osteoprotegerin expression in prostate cancer cells. | 2007 | Prostate Cancer Prostatic Dis. | pmid:17189957 |
| Jia L and Jin TY | Combined effect of fluoride and arsenate on gene expression of osteoclast differentiation factor and osteoprotegerin. | 2006 | Biomed. Environ. Sci. | pmid:17190191 |
| Rauner M et al. | Osteoimmunology. | 2007 | Int. Arch. Allergy Immunol. | pmid:17191007 |
| McClung MR | Looking for answers in all the wrong places. | 2007 Jan-Feb | Menopause | pmid:17194959 |
| Mori K et al. | DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process. | 2007 | Bone | pmid:17196895 |
| Li Y et al. | B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. | 2007 | Blood | pmid:17202317 |
| Mada Y et al. | Effects of endogenous and exogenous prostaglandin E2 on the proliferation and differentiation of a mouse cementoblast cell line (OCCM-30). | 2006 | J. Periodontol. | pmid:17209790 |
| Nagasawa T et al. | Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. | 2007 | Periodontol. 2000 | pmid:17214836 |
| D'Amore M et al. | Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women. | 2006 | Panminerva Med | pmid:17215793 |
| Park H et al. | Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17222389 |
| McKenna MJ and Kristiansen AG | Molecular biology of otosclerosis. | 2007 | Adv. Otorhinolaryngol. | pmid:17245026 |
| Helske S et al. | Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload. | 2007 | Eur. J. Heart Fail. | pmid:17254844 |
| Guldiken B et al. | Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. | 2007 | Thromb. Res. | pmid:17258300 |
| Mazzaferro S et al. | Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. | 2007 | Am. J. Nephrol. | pmid:17259697 |
| Ozkaya O et al. | Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis. | 2007 | Nephron Clin Pract | pmid:17259742 |
| Tsirpanlis G | Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease? | 2007 | Blood Purif. | pmid:17261926 |
| Simsek S et al. | Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects. | 2007 | J. Clin. Endocrinol. Metab. | pmid:17284635 |
| Baud'huin M et al. | Key roles of the OPG-RANK-RANKL system in bone oncology. | 2007 | Expert Rev Anticancer Ther | pmid:17288531 |
| Abedin M et al. | Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). | 2007 | Am. J. Cardiol. | pmid:17293196 |
| Hjertner Ø et al. | Bone disease in multiple myeloma. | 2006 | Med. Oncol. | pmid:17303901 |
| Cui NH et al. | [Osteoclastic bone destruction and its regulating factors in oral squamous cell carcinoma]. | 2007 | Beijing Da Xue Xue Bao | pmid:17304322 |
| Tang XL et al. | [Effect of 17-beta estradiol on the expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation]. | 2007 | Beijing Da Xue Xue Bao | pmid:17304327 |
| César-Neto JB et al. | Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues. | 2007 | J. Periodont. Res. | pmid:17305878 |